221 studies found for:    Ankylosing Spondylitis
Show Display Options
Rank Status Study
1 Completed
Has Results
A Study of Adalimumab in Japanese Subjects With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Biological: adalimumab
2 Completed
Has Results
Safety and Efficacy of Adalimumab in Patients With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: adalimumab (D2E7);   Biological: placebo
3 Active, not recruiting Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis
Conditions: Ankylosing Spondylitis;   Psoriatic Arthritis
Intervention:
4 Completed
Has Results
Study Evaluating Etanercept for the Treatment of Active, Severe, and Advanced Axial Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: Etanercept (Enbrel);   Other: Placebo
5 Completed
Has Results
Study Evaluating Etanercept in Subjects With Ankylosing Spondylitis in Spain
Condition: Ankylosing Spondylitis
Interventions: Drug: etanercept;   Drug: etanercept/placebo
6 Active, not recruiting Safety and Effectiveness of Adalimumab (Humira) in Patients With Ankylosing Spondylitis in Clinical Routine
Condition: Ankylosing Spondylitis
Intervention:
7 Completed
Has Results
Human Anti-tumor Necrosis Factor (TNF) Monoclonal Antibody Adalimumab in Subjects With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: adalimumab (D2E7);   Biological: placebo
8 Completed
Has Results
Study Evaluating Etanercept and Sulphasalazine in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: etanercept;   Drug: sulphasalazine (SSZ)
9 Recruiting Impact of Adalimumab (Humira) Therapy on Selected Health Care Resource Utilization and Sick Leave in Patients With Ankylosing Spondylitis in Clinical Practice
Condition: Ankylosing Spondylitis
Intervention:
10 Completed
Has Results
Study of the Safety and Efficacy of Golimumab in Chinese Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: Placebo;   Drug: Golimumab;   Drug: Golimumab (placebo group)
11 Recruiting Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: Tofacitinib 2 mg;   Drug: Tofacitinib 5 mg;   Drug: Tofacitinib 10 mg;   Drug: Placebo
12 Completed
Has Results
Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Biological: adalimumab;   Other: placebo
13 Completed Efficacy of AIN457 in Adults (18-65 Years) With Moderate to Severe Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Interventions: Drug: AIN457;   Drug: ARIN457
14 Active, not recruiting Assessment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients`Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice
Conditions: Rheumatoid Arthritis;   Ankylosing Spondylitis;   Psoriatic Arthritis
Intervention:
15 Completed
Has Results
Assessment of Pain Management in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Patients Who Are About to be Treated With Adalimumab
Conditions: Rheumatoid Arthritis;   Ankylosing Spondylitis;   Psoriatic Arthritis
Intervention:
16 Completed
Has Results
Study Evaluating Predictors of Response in Patients With Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Other: Treatment switching
17 Completed
Has Results
Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) After Unsustainable Response to Biologicals and Disease Modifying Antirheumatic Drugs
Conditions: Rheumatoid Arthritis;   Ankylosing Spondylitis;   Psoriatic Arthritis
Intervention:
18 Recruiting Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)
Condition: Ankylosing Spondylitis
Intervention:
19 Completed
Has Results
A Study of the Safety and Efficacy of Golimumab in Subjects With Active Ankylosing Spondylitis
Condition: Spondylitis, Ankylosing
Interventions: Biological: golimumab;   Biological: Golimumab (CNTO 148); placebo
20 Completed
Has Results
Extension Study Evaluating Etanercept in Ankylosing Spondylitis
Condition: Ankylosing Spondylitis
Intervention: Drug: Enbrel (etanercept)

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years